摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5,15-Bis(4-fluoro-3-methylphenyl)-10,20-bis(4-methoxyphenyl)porphyrin | 132313-40-7

中文名称
——
中文别名
——
英文名称
5,15-Bis(4-fluoro-3-methylphenyl)-10,20-bis(4-methoxyphenyl)porphyrin
英文别名
——
5,15-Bis(4-fluoro-3-methylphenyl)-10,20-bis(4-methoxyphenyl)porphyrin化学式
CAS
132313-40-7
化学式
C48H36F2N4O2
mdl
——
分子量
738.836
InChiKey
JGEGDRMXQSEAKN-UDTYQVGYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    12.24
  • 重原子数:
    56.0
  • 可旋转键数:
    6.0
  • 环数:
    9.0
  • sp3杂化的碳原子比例:
    0.08
  • 拓扑面积:
    75.82
  • 氢给体数:
    2.0
  • 氢受体数:
    4.0

反应信息

点击查看最新优质反应信息

文献信息

  • Rational tetraarylporphyrin syntheses: tetraarylporphyrins from the MacDonald route
    作者:David M. Wallace、Sam H. Leung、Mathias O. Senge、Kevin M. Smith
    DOI:10.1021/jo00077a056
    日期:1993.12
    Four new synthetic routes to meso-tetraarylporphyrins using a MacDonald-type 2 + 2 condensation are described. Self-condensation of a 5-aryldipyrromethane (e.g., 17) with an aryl-substituted one-carbon bridging unit affords a mixture of tetraarylporphyrins due to acid-catalyzed redistribution reactions. The second and third methods presented here show wide applicability for the preparation of 5,10,15,20-tetraaryl-substituted porphyrins (e.g., 31, 37, 48, 49) with 2-fold rotational symmetry and involve self-condensation of 5-aryl-1-aryldipyrromethanecarbinols. Finally, the fourth approach involves a 2 + 2 approach in which one of the two dipyrromethanes bears both of the bridging carbons in the porphyrin products, affording porphyrin 50 which possesses three different aryl rings, with one pair of uniquely opposite identical aryl groups. The last two 2 + 2 methods are further extended to give a tetraarylporphyrin 38 bearing four different aryl groups in a predesignated array, the structure of which is confirmed by a single-crystal X-ray study.
  • Sickled Erythrocytes with Anti-tumor Agents Induce Tumor Vaso-occlusion and Tumoricidal Effects
    申请人:Terman David S.
    公开号:US20120195869A1
    公开(公告)日:2012-08-02
    The present invention provides erythrocytes or nucleated erythrocyte precursors from animals or patients with at least one S hemoglobin allele which are capable of selectively localizing in tumor vasculature resulting in vaso-occlusion, hemolysis and heme release. A tumoricidal effect is achieved when these cells are administered in before during or after administration of (i) an agent(s) that interferes with degradation of reactive oxygen species, (ii) impairs glucose uptake and/or (iii) chemotherapy. These cells also carry oncolytic viruses, antitumor proteins, multidrug resistant proteins, chemotherapy, monoclonal antibodies, superantigens, superantigen conjugates and fusion proteins, siRNAs, plasmids and non-protein toxins and attenuated tumoricidal bacterial cells specifically into the tumors and induce a tumoricidal effect.
  • US8431117B2
    申请人:——
    公开号:US8431117B2
    公开(公告)日:2013-04-30
查看更多